Literature DB >> 27134254

NLRP3 A439V Mutation in a Large Family with Cryopyrin-associated Periodic Syndrome: Description of Ophthalmologic Symptoms in Correlation with Other Organ Symptoms.

Bianka Sobolewska1, Eva Angermair2, Christoph Deuter2, Deshka Doycheva2, Jasmin Kuemmerle-Deschner2, Manfred Zierhut2.   

Abstract

OBJECTIVE: Cryopyrin-associated periodic syndrome (CAPS) is a group of inherited autoinflammatory disorders caused by mutations in the NLRP3 gene resulting in the overproduction of interleukin 1β. NLRP3 mutations cause a broad clinical phenotype of CAPS. The aims of the study were to evaluate clinical, laboratory, and genetic features of a 5-generation family with CAPS focusing in detail on ocular symptoms.
METHODS: In a retrospective observational cohort study, consecutive family members were screened for the presence of the NLRP3 mutation. Patients underwent standardized clinical, laboratory, and ophthalmological assessments. The genotype-specific risk of ophthalmological findings and other organ symptoms was determined.
RESULTS: Twenty-nine patients were clinically affected. The A439V mutation encoded by exon 3 of the NLRP3 gene was found in 15 of 37 family members (41%). The most common clinical features were musculoskeletal symptoms, headaches, and ophthalmological symptoms. The mutation-positive patients were characterized by more frequent skin rashes, ocular symptoms, arthralgia, arthritis, and severe Muckle-Wells syndrome (MWS) Disease Activity Score. Rosacea was diagnosed in 8 patients.
CONCLUSION: The NLRP3 mutation A439V is associated with a heterogeneous clinical spectrum of familial cold autoinflammatory syndrome/MWS-overlap syndrome. Skin rash and eye diseases, such as conjunctivitis and uveitis, were positively correlated with this mutation.

Entities:  

Keywords:  FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; MUCKLE-WELLS SYNDROME; NLRP3 MUTATION; ROSACEA; UVEITIS

Mesh:

Substances:

Year:  2016        PMID: 27134254     DOI: 10.3899/jrheum.150681

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Cryopyrin-associated periodic syndrome presenting with posterior scleritis.

Authors:  Erica R Alvarez; Brady Corless; Apostolos Kontzias; Colleen M Cebulla
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

2.  The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.

Authors:  Micol Romano; Z Serap Arici; David Piskin; Sara Alehashemi; Daniel Aletaha; Karyl Barron; Susanne Benseler; Roberta A Berard; Lori Broderick; Fatma Dedeoglu; Michelle Diebold; Karen Durrant; Polly Ferguson; Dirk Foell; Jonathan S Hausmann; Olcay Y Jones; Daniel Kastner; Helen J Lachmann; Ronald M Laxer; Dorelia Rivera; Nicola Ruperto; Anna Simon; Marinka Twilt; Joost Frenkel; Hal M Hoffman; Adriana A de Jesus; Jasmin B Kuemmerle-Deschner; Seza Ozen; Marco Gattorno; Raphaela Goldbach-Mansky; Erkan Demirkaya
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

Review 3.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

4.  The NLRP3 p.A441V Mutation in NLRP3-AID Pathogenesis: Functional Consequences, Phenotype-Genotype Correlations and Evidence for a Recurrent Mutational Event.

Authors:  Fawaz Awad; Eman Assrawi; Claire Jumeau; Sylvie Odent; Veronique Despert; Gérard Cam; Aleth Perdriger; Camille Louvrier; Laetitia Cobret; Bruno Copin; Sandra Chantot-Bastaraud; Philippe Duquesnoy; William Piterboth; Claire Le Jeunne; Genevieve Quenum-Miraillet; Jean Pierre Siffroi; Sophie Georgin-Lavialle; Gilles Grateau; Marie Legendre; Irina Giurgea; Sonia-Athina Karabina; Serge Amselem
Journal:  ACR Open Rheumatol       Date:  2019-06-06

5.  Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.

Authors:  Jasmin Beate Kuemmerle-Deschner; Raju Gautam; Aneesh Thomas George; Syed Raza; Kathleen Graham Lomax; Peter Hur
Journal:  RMD Open       Date:  2020-07

6.  Behçet's Syndrome in a Chinese Pedigree of NLRP3-Associated Autoinflammatory Disease: A Coexistence or Novel Presentation?

Authors:  Jinjing Liu; Xin Yu; Chaoran Li; Yi Wang; Weihong Yu; Min Shen; Wenjie Zheng
Journal:  Front Med (Lausanne)       Date:  2021-06-24

7.  Ocular manifestations in Chinese adult patients with NLRP3-associated autoinflammatory disease.

Authors:  Tianli Meng; Di Wu; Yi Luo; Na Wu; Mengzhu Zhao; Min Shen; Weihong Yu
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

8.  Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome.

Authors:  Toshihiko Matsuo; Masato Yashiro; Osamu Yamasaki; Takehiro Tanaka; Akira Manki
Journal:  Life (Basel)       Date:  2021-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.